Abstract:Background: Gadolinium-based contrast agents (GBCAs) are widely used to enhance tissue contrast during MRI scans and play a crucial role in the management of patients with cancer. However, studies have shown gadolinium deposition in the brain after repeated GBCA administration with yet unknown clinical significance. We aimed to assess the feasibility and diagnostic value of synthetic post-contrast T1-weighted MRI generated from pre-contrast MRI sequences through deep convolutional neural networks (dCNN) for tumour response assessment in neuro-oncology. Methods: In this multicentre, retrospective cohort study, we used MRI examinations to train and validate a dCNN for synthesising post-contrast T1-weighted sequences from pre-contrast T1-weighted, T2-weighted, and fluid-attenuated inversion recovery sequences. We used MRI scans with availability of these sequences from 775 patients with glioblastoma treated at Heidelberg University Hospital, Heidelberg, Germany (775 MRI examinations); 260 patients who participated in the phase 2 CORE trial (1083 MRI examinations, 59 institutions); and 505 patients who participated in the phase 3 CENTRIC trial (3147 MRI examinations, 149 institutions). Separate training runs to rank the importance of individual sequences and (for a subset) diffusion-weighted imaging were conducted. Independent testing was performed on MRI data from the phase 2 and phase 3 EORTC-26101 trial (521 patients, 1924 MRI examinations, 32 institutions). The similarity between synthetic and true contrast enhancement on post-contrast T1-weighted MRI was quantified using the structural similarity index measure (SSIM). Automated tumour segmentation and volumetric tumour response assessment based on synthetic versus true post-contrast T1-weighted sequences was performed in the EORTC-26101 trial and agreement was assessed with Kaplan-Meier plots. Findings: The median SSIM score for predicting contrast enhancement on synthetic post-contrast T1-weighted sequences in the EORTC-26101 test set was 0·818 (95% CI 0·817-0·820). Segmentation of the contrast-enhancing tumour from synthetic post-contrast T1-weighted sequences yielded a median tumour volume of 6·31 cm3 (5·60 to 7·14), thereby underestimating the true tumour volume by a median of -0·48 cm3 (-0·37 to -0·76) with the concordance correlation coefficient suggesting a strong linear association between tumour volumes derived from synthetic versus true post-contrast T1-weighted sequences (0·782, 0·751-0·807, p<0·0001). Volumetric tumour response assessment in the EORTC-26101 trial showed a median time to progression of 4·2 months (95% CI 4·1-5·2) with synthetic post-contrast T1-weighted and 4·3 months (4·1-5·5) with true post-contrast T1-weighted sequences (p=0·33). The strength of the association between the time to progression as a surrogate endpoint for predicting the patients' overall survival in the EORTC-26101 cohort was similar when derived from synthetic post-contrast T1-weighted sequences (hazard ratio of 1·749, 95% CI 1·282-2·387, p=0·0004) and model C-index (0·667, 0·622-0·708) versus true post-contrast T1-weighted MRI (1·799, 95% CI 1·314-2·464, p=0·0003) and model C-index (0·673, 95% CI 0·626-0·711). Interpretation: Generating synthetic post-contrast T1-weighted MRI from pre-contrast MRI using dCNN is feasible and quantification of the contrast-enhancing tumour burden from synthetic post-contrast T1-weighted MRI allows assessment of the patient's response to treatment with no significant difference by comparison with true post-contrast T1-weighted sequences with administration of GBCAs. This finding could guide the application of dCNN in radiology to potentially reduce the necessity of GBCA administration. Funding: Deutsche Forschungsgemeinschaft.

Synthesizing Contrast-Enhanced MR Images from Noncontrast MR Images Using Deep Learning

Synthesizing MR Image Contrast Enhancement Using 3D High-Resolution ConvNets

Magnetic Resonance Imaging Contrast Enhancement Synthesis Using Cascade Networks with Local Supervision

A Novel Method Of Synthetic Ct Generation From Mr Images Based On Convolutional Neural Networks

MRI Contrast Enhancement Synthesis Using Cascade Networks with Local Supervision

Deep Learning-Based Contrast-Enhanced MRI Using Cascade Networks with Local Supervision

Deep Learning‐Based 3D MRI Contrast‐Enhanced Synthesis From A 2D Non‐contrast T2Flair Sequence Deep Learning, MR images Synthesis

Deep learning-based 3D MRI contrast-enhanced synthesis from a 2D noncontrast T2Flair sequence

Artificial T1-Weighted Postcontrast Brain MRI: A Deep Learning Method for Contrast Signal Extraction

Synthesis of gadolinium‐enhanced glioma images on multisequence magnetic resonance images using contrastive learning

T1-contrast Enhanced MRI Generation from Multi-parametric MRI for Glioma Patients with Latent Tumor Conditioning

Gadolinium dose reduction for brain MRI using conditional deep learning

Synthesize High-Quality Multi-Contrast Magnetic Resonance Imaging from Multi-Echo Acquisition Using Multi-Task Deep Generative Model

Artificial T1-Weighted Postcontrast Brain MRI

Generative adversarial network-based synthesis of contrast-enhanced MR images from precontrast images for predicting histological characteristics in breast cancer

Contrast-enhanced MRI Synthesis from Non-Contrast MRI Using Attention CycleGAN

Deep learning‐based convolutional neural network for intramodality brain MRI synthesis

Deep learning based MRI contrast synthesis using full volume prediction using full volume prediction

Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study

Enhanced Magnetic Resonance Image Synthesis with Contrast-Aware Generative Adversarial Networks

Synthesis of Brain Tumor MR Images for Learning Data Augmentation